Global heart valve study seeks to uncover hidden differences in patients before treatment

NCT ID NCT07258706

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study enrolls 800 people with severe aortic stenosis who are scheduled for a TAVI procedure (a less invasive heart valve replacement). Researchers will compare participants from different countries using CT scans of the heart and blood tests to measure inflammation. The goal is to understand how anatomy and lab results vary across populations, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Bilkent City Hospital, Ankara, Türkiye

    Ankara, Turkey (Türkiye)

  • Institute for Cardiovascular Diseases of Vojvodina, Serbia University of Novi Sad

    Novi Sad, Serbia

  • King Chulalongkorn Memorial Hospital, Bangkok, Thailand

    Bangkok, Thailand

  • Poznan University of Medical Sciences

    Poznan, 61-848, Poland

  • San Bortolo's Hospital, Division of Cardiac Surgery and Division of Cardiology, Vicenza, Italy

    Vicenza, Italy